Vasomotion of coronary arteries: From nitrates to nitric oxide

Cardiovascular Drugs and Therapy

Volumn 13, Issue 4, 1999, Pages 295-300

  Tousoulis, Dimitris ^a,b   Davies, Graham J ^a,b   Toutouzas, Pavlos C ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Coronary artery disease; Nitrates; Nitric oxide; Stable angina; Vasomotion

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; GLYCERYL TRINITRATE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADRENERGIC SYSTEM; ANGINA PECTORIS; ARTERY OCCLUSION; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; ENDOCARDIUM; HUMAN; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RABBIT; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; BIOLOGICAL FACTORS; CARDIOVASCULAR AGENTS; CLINICAL TRIALS; CORONARY VESSELS; CYCLIC GMP; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRATES; NITRIC OXIDE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0032841125     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007747114386     Document Type: Review

References (60)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
2. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cruanosine monophosphate. Circ Res 1983;52: 352-357.
3. Berkenboom G, Unger P, Fang ZY, Degre S, Fontaine J, Comparison of the responses to acetylcholine and serotonin on isolated canine and human coronary arteries. Cardiovasc Res 1989;23:780-787.
4. Crossman DC, Larkin SW, Fuller RW, Davies GJ, Maseri A. Substrance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation 1989;80: 475-484.
5. Luscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993;87(suppl V):V-36-V-44.
6. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-1051.
7. Collins P, Burman J, Chung H-I, Fox K. Hemoglobins inhibits endothelium-derived relaxation to acetylcholine in human coronary arteries in vivo. Circulation 1993;87:80-6.
8. Luscher TF, Boulanger CM, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension 1992;19:117-130.
9. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 1989;80: 1-9.
10. Vanhoutte PM. The endothelium. Modulator of vascular smooth muscle tone. N Engl J Med 1988;319:512-513.
11. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666.
12. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
13. Ignaro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
14. Chu A, Chambers DE, Lin C, Kuehl WD, Cobb FR. Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. Am J Physiol 1990;258:H1250-H1254.
15. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Bioch Biophys Res Commun 1993;191:89-94.
16. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependend relaxation. Br J Pharmacol 1989;96:418-424.
17. 2--independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992;105:575-580.
18. Waldman SA, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the granylate cyclasecyclic GMP system. J Cardiovasc Pharmacol 1988;12:Suppl 5:S115-S118.
19. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: How much is beneficial? Lancet 1991;338:1555-1557.
20. Busse R, Mulsch A, Fleming I, Hecker M. Mechanisms of nitric release from the vascular endothelium. Circulation 1993;87[Suppl V]:V18-V25.
21. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
22. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
23. Perrella MA, Hildebrand FL, Margulies KB, Burnett JC Jr. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J Physiol 1991; 261:R323-R328.
24. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-497.
25. Tousoulis D, Davies G, Lefroy DC, Haider AW, Crake T. Variable coronary vasomotor responses to acetylcholine in patients with normal coronary arteriograms: Evidence for localised endothelial dysfunction. Heart 1996;75:261-266.
26. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early atherosclerosis. Circulation 1990;81:482-490.
27. Tousoulis D, Davies G, Tentolouris C, Crake T, Toutouzas P, Inhibition of nitric oxide synthesis during the cold pressor test in patients with coronary artery disease. Am J Cardiol 1997;79:1676-1679.
28. Tousoulis D, Tentolouris C, Crake T, Toutouzas P, Davies G. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries. J Am Coll Cardiol 1997;29:1256-1262.
29. Tousoulis D, Crake T, Tentolouris C, Lefroy DC, Gialafos J, Toutouzas P, Davies G. Effects of inhibition of nitric oxide synthesis in proximal and distal segments in patients with normal arteries and in patients with coronary artery disease. J Am Coll Cardiol 1995(Suppl):117A
30. Horio Y, Yasue H, Rokutanda M, et al. Effects of intracoronary injection of acetylcholine in atherosclerotic coronary arteries. Am J Cardiol 1986;57:981-989.
31. Tousoulis D, Crake T, Kaski JC, Rosen S, Haider AW, Davies G. Enhanced vasomotor responses of complex stenoses to acetylcholine in patients with chronic stable angina. Am J Cardiol 1995;75:725-728.
32. Hodgson JMCB, Marshall J. Direct vasoconstriction and endothelium-dependent vasodilation: Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 1989:79:1043-1051.
33. Newman CM, Maseri A, Hackett D, El-Tamimi HM, Davies G.T. Response of angiographically normal and atherosclerotic left anterior descending coronary arteries to acetylcholine. Am J Cardiol 1990;66:1070-1076.
34. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
35. El Tamimi H, Mansour M, Wargovich TJ, et al. Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease: Endothelial function revisited. Circulation 1994;89:45-51.
36. Tousoulis D, Davies GJ, Tentolouris C, Crake T, Lefroy DC, Toutouzas P. Effects of inhibition of nitric oxide synthesis in patients with coronary artery disease and stable angina. Eur Heart J 1997;18:608-613.
37. Tousoulis D, Crake T, Davies G, Tentolouris C, Toutouzas P. Basal nitric oxide production by diseased coronary arteries. J Am Coll Cardiol 1994;28:1639.
38. Buttery LDK, Springall DR, Chester AH, et al. Inducible NO synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996;75:77-85.
39. Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of granylate cyclase. Eur J Pharmacol 1987; 139:19-30.
40. Busse K, Pohl U, Mulssch A, Bassenge E. Modulation of the vasodilator action of SIN-1 by the endothelium. J Cardiovasc. Pharmacol 1989;14(Suppl 11):S81-S85
41. Luscher TF, Richards V, Yang ZH. Interaction between endothelium derived nitric oxide and SIN-1 in human and porcine blond vessels. J Cardiovasc Pharmacol 1989;14 (Suppl 11):S76-S80
42. Abrams J. Clinical aspects of nitrate tolerance. Eur Heart J 1991;12(Suppl E):42-52
43. Jones CJH, Kuo L, Davis M, Chilian WM. In vivo and in vitro vasoactive reactions of coronary arteriolar microvessels to nitroglycerin. Am J Physiol 1996;271:H461-H468.
44. Brown BG. Responses of normal and diseased epicardial coronary arteries to vasoactive drugs: Quantitative arteriographic studies. Am J Cardiol 1985;56:23E-29E.
45. Tousoulis D, Kaski JC, Bogaty P, et al. Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris. Am J Cardiol 1991;67:1195-1200.
46. Gorlin R, Brachfield N, Macleod C, Bopp P. Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work. Circulation 1959; 19:705-718.
47. Vatner SF. Effects of nitroglycerin on cardiac function and regional blood flow distribution in conscious dog. Am J Physiol 1978;234:H244-H252
48. Winbury M, Howe BB, Hefner MA. Effects of nitrates and other coronary dilators on large and small coronary vessels: A hypothesis for the mechanisms of action of nitrates. J Pharmacol Exp Ther 1969;168:70-95.
49. 2 and adenosine. Am J Physiol 1972;223:223-228.
50. Cohen MV, Kirk ES. Differential response of large and small coronary arteries to nitroglycerin and angiotensin. Autoregulation and tachyphylaxis. Circ Rex 1973;33:445-453.
51. Vlodaver Z, Edwards JE. Pathology of coronary atherosclerosis. Prog Cardiovasc Dis 1971;14:256-274.
52. Freudenberg H, Lichtlen PR. The normal wall segment in coronary stenosis - A postmortem study. Z Kardiol 1981;70: 863-869.
53. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: Stenosis vasodilatation as a major component to the drug response. Circulation 1981;64:1089-1097.
54. Brown BG, Bolson EL, Dodge HT. Dynamic mechanisms in human coronary stenosis. Circulation 1984;48:797-803.
55. Kaski JC, Tousoulis D, Haider WA, Gavrielides S, Crea F, Maseri A. Reactivity of eccentric and concentric stenoses in chronic stable angina. J Am Coll Cordial 1991;17:627-633.
56. Simonetti I, De Caterina R, Michelassi C, Marzilli M, De Nes M, E Abbate A. Coronary vasodilation by nitrates is not mediated by the prostaglandin system: A quantitative cineangiographic study. J Am Coll Cardiol 1986;8: 1263-1270.
57. Feldman K, Marx D, Pepine C, Conti R. Analysis of coronary responses to various doses of intracoronary nitroglycerin. Circulation 1982;66:321-327.
58. Rafflenbeul W, Urthaler F, Russel R, Lichtlen P, James T. Dilatation of coronary artery stenoses after isosorbide dinitrate in man. Br Heart J 1980;43:546-549.
59. Santamore W, Walinsky P. Altered coronary flow responses to vasoactive drugs in the presence of arterial stenosis in the dog. Am J Cardiol 1980;45:276-285.
60. Feldman R, Pepine C, Conti K. Magnitude of dilatation of large and small coronary arteries by nitroglycerin. Circulation 1981;64:324-333.